Philips and WellSpan Health announced a seven-year strategic alliance covering joint research, AI and digital-tool evaluation, and a commercial agreement naming Philips the preferred vendor across several imaging modalities.
Industrial & Manufacturing · Netherlands
Previously: Philips announced a 2026–2028 plan built on segment-specific growth strategies, platform-based innovation and disciplined execution. It set targets including mid-single-digit comparable-sales CAGR, a mid-teens adjusted EBITA margin in 2028, cumulative free cash flow of EUR 4.5–5.0 billion, and EUR 1.5 billion of productivity savings.
Read maintained: 2026-10-07